Acyclovir vs Pembrolizumab

## Acyclovir vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between **Acyclovir** and **Pembrolizumab**.

## Mechanism of Action

**Acyclovir**: Guanosine analogue inhibiting viral DNA polymerase.

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

## Pharmacokinetics

**Half-life**: Acyclovir — 2.5-3.3 hours; Pembrolizumab — 26 days.

## Chemical Properties

**Molecular Formula**: Acyclovir — C8H11N5O3; Pembrolizumab — N/A.

**Molecular Weight**: Acyclovir — 225.2050 g/mol; Pembrolizumab — N/A.

**Type**: Acyclovir — Small molecule; Pembrolizumab — Antibody.